Brief: Biosynex FY Revenue Jumps To EUR 154 Million
Jan 21 (Reuters) - Biosynex SA ALBIO.PA :
* 2020 REVENUE EUR 154 MILLION
* FY REVENUE EUR 154.0 MLN VERSUS EUR 35.2 MLN YR AGO
* SEES CONTINUED SALES MOMENTUM IN 2021
* ANTICIPATES VERY STRONG GROWTH IN ITS OPERATIONAL
PROFITABILITY
INDICATORS IN A MUCH HIGHER PROPORTION THAN THAT OBSERVED FOR
THE HALF-YEAR RESULTS
Source text for Eikon: ID:nBw78gp1Va
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals